Overview Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes Status: Completed Trial end date: 2003-10-15 Target enrollment: Participant gender: Summary This trial is conducted in Europe. The aim of this trial is to evaluate safety and efficacy in children with type 1 diabetes. Phase: Phase 4 Details Lead Sponsor: Novo Nordisk A/STreatments: InsulinInsulin AspartInsulin degludec, insulin aspart drug combinationInsulin, Globin ZincInsulin, IsophaneInsulin, Long-ActingIsophane insulin, beefIsophane Insulin, Human